Chembio Diagnostics, Inc. (CEMI) Shares Bought by Wells Fargo & Company MN
Wells Fargo & Company MN increased its holdings in Chembio Diagnostics, Inc. (NASDAQ:CEMI) by 55.4% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 74,186 shares of the company’s stock after acquiring an additional 26,436 shares during the quarter. Wells Fargo & Company MN owned about 0.60% of Chembio Diagnostics worth $449,000 as of its most recent filing with the Securities & Exchange Commission.
Separately, Royce & Associates LP bought a new position in Chembio Diagnostics in the second quarter worth $132,000. 30.57% of the stock is owned by institutional investors and hedge funds.
Chembio Diagnostics, Inc. (CEMI) opened at $6.75 on Tuesday. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.54 and a quick ratio of 2.19. Chembio Diagnostics, Inc. has a twelve month low of $5.05 and a twelve month high of $7.05.
ILLEGAL ACTIVITY WARNING: This piece was posted by Watch List News and is owned by of Watch List News. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at https://www.watchlistnews.com/chembio-diagnostics-inc-cemi-shares-bought-by-wells-fargo-company-mn/1701622.html.
Separately, ValuEngine upgraded Chembio Diagnostics from a “strong sell” rating to a “sell” rating in a report on Friday, August 11th.
Chembio Diagnostics Profile
Chembio Diagnostics, Inc (Chembio), and its subsidiary, Chembio Diagnostic Systems, Inc, develop, manufacture, market and license rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. The Company’s products available are rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies, and a multiplex rapid test for the detection of HIV and Syphilis antibodies.
Want to see what other hedge funds are holding CEMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chembio Diagnostics, Inc. (NASDAQ:CEMI).
Receive News & Ratings for Chembio Diagnostics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chembio Diagnostics Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.